β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis
Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics
Genetic diversity among methicillin-resistant Staphylococcus aureus isolates carrying the mecC gene in Belgium
High frequency and diversity of cassette chromosome recombinases ( ccr ) in methicillin-susceptible Staphylococcus sciuri
Mechanism for transfer of transposon Tn 2010 carrying macrolide resistance genes in Streptococcus pneumoniae and its effects on genome evolution
What causes decreased erythromycin resistance in Streptococcus pyogenes ? Dynamics of four clones in a southern European region from 2005 to 2012
Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202
High diversity of plasmids harbouring bla CMY-2 among clinical Escherichia coli isolates from humans and companion animals in the upper Midwestern USA
Vertical transmission of Escherichia coli carrying plasmid-mediated AmpC (pAmpC) through the broiler production pyramid
Role of inter-species recombination of the ftsI gene in the dissemination of altered penicillin-binding-protein-3-mediated resistance in Haemophilus influenzae and Haemophilus haemolyticus
Unique combined penA / mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a ‘susceptible' Neisseria gonorrhoeae population
Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?
High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform
Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients
Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains
Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants
Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication
Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals
Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime
In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae
Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12)
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model
Pyrrolo[1,2-α][1,4]benzodiazepines show potent in vitro antifungal activity and significant in vivo efficacy in a Microsporum canis dermatitis model in guinea pigs
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration
Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)
Dramatic increase in vancomycin-resistant enterococci in Germany
Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy
Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy
Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study
Long-term adherence to a 5 day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections
Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases
Antibiotic use in Dutch primary care: relation between diagnosis, consultation and treatment
Performance of the Abbott RealTime HIV-1 assay versus the Roche Amplicor HIV-1 MonitorTM Test, v1.5, UltraSensitive assay for samples with low plasma HIV-1 RNA copy numbers
Impact of test methodology, media type and ion content on the susceptibility of Acinetobacter spp. to tigecycline
In vitro and intracellular activity of 4-substituted piperazinyl phenyl oxazolidinone analogues against Mycobacterium tuberculosis
Avibactam activity against extended-spectrum AmpC β-lactamases
In vitro activity of ceftaroline against Burkholderia pseudomallei
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent
Comment on: Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent—authors' response
Comment on: Current initiatives to improve prudent antibiotic use amongst school-aged children